Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients

  1. Vázquez, L.
  2. Encinas, M.P.
  3. Morín, L.S.
  4. Vilches, P.
  5. Gutiérrez, N.
  6. García-Sanz, R.
  7. Caballero, D.
  8. Hurlé, A.
  9. San Miguel, J.F.
Aldizkaria:
Haematologica

ISSN: 0390-6078

Argitalpen urtea: 1999

Alea: 84

Zenbakia: 3

Orrialdeak: 231-236

Mota: Artikulua